Overview
AOD‑9604 is a modified fragment of human growth hormone (HGH 176–191) designed for use in in vitro and laboratory‑based research involving metabolic signaling pathways and adipocyte‑related biochemical mechanisms. It is widely utilized in studies examining peptide‑mediated regulation of lipid‑metabolism models and energy‑balance pathways.
Molecular Characteristics
Peptide Type: HGH‑derived fragment analog
Form: Lyophilized powder
Purity: ≥ 98% (HPLC)
Storage: –20°C recommended
Research Applications
AOD‑9604 is commonly investigated in controlled laboratory environments for:
Lipid‑metabolism pathway analysis
Assay development involving adipocyte signaling
In vitro modeling of energy‑regulation mechanisms
Biochemical exploration of peptide‑mediated metabolic pathways
Studies involving growth‑hormone fragment activity
(All framed as research domains, not biological outcomes.)
Mechanistic Notes (Research Context Only)
In laboratory settings, AOD‑9604 is studied for its interaction with:
Lipid‑oxidation and lipogenesis‑related pathways
Metabolic‑signaling models involving adipocyte activity
Cellular energy‑balance mechanisms under controlled conditions
These statements describe mechanistic interest, not biological effects in humans or animals.
Storage & Handling
Store lyophilized peptide at –20°C
Avoid repeated freeze–thaw cycles
Handle reconstituted solutions according to laboratory best practices
Important Research Notice
For laboratory research use only
Not for human consumption
Not for drug, food, or cosmetic use
Not for veterinary or household use
No medical or therapeutic claims are made